医学
前列腺癌
阉割
肿瘤科
前列腺
内科学
泌尿科
癌症
激素
作者
Gengcuo Qu,Qingchu Hua,Hongmei Li,Yu Zhang,Yue Chen
标识
DOI:10.1097/rlu.0000000000005010
摘要
Abstract We report a 65-year-old man with metastatic castration-resistant prostate cancer who was treated with 2 cycles of 177 Lu-PSMA-617 therapy. PET/CT imaging of 68 Ga-PSMA-11 revealed a complete metabolic response (PERCIST1.0) after therapy. The prostate-specific antigen concentration drastically decreased (97.7% down).
科研通智能强力驱动
Strongly Powered by AbleSci AI